APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amiodarone

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Amiodarone Market Outlook and Growth Opportunities 2026

21 December 2025198 pages

Choose your research edition.

Industry ResearchAmiodarone Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Amiodarone Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Amiodarone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amiodarone Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Amiodarone Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Amiodarone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Amiodarone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Amiodarone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amiodarone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Amiodarone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Amiodarone market include Shanghai Pharmaceuticals, Sanofi, Mylan Pharmaceuticals, North China Pharmaceutical Company, Harbin Pharmaceutical Group, Wyeth Pharmaceuticals (Pfizer), Sawai Pharmaceutical, Roemmers and Cipla Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Amiodarone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Amiodarone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Amiodarone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amiodarone market size, projected growth trends, production technologies, key applications, and end-use industries.

Amiodarone Segment by Company

Shanghai Pharmaceuticals

Sanofi

Mylan Pharmaceuticals

North China Pharmaceutical Company

Harbin Pharmaceutical Group

Wyeth Pharmaceuticals (Pfizer)

Sawai Pharmaceutical

Roemmers

Cipla Pharmaceutical

Arrow Pharma Pty Ltd

Amiodarone Segment by Type

Injection Amiodarone

Tablet Amiodarone

Capsule Amiodarone

Amiodarone Segment by Application

Ventricular Tachycardia

Atrial Fibrillation

Cardiac Arrest

Others

Amiodarone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Amiodarone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Amiodarone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Amiodarone significant trends, drivers, influence factors in global and regions.

6. To analyze Amiodarone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amiodarone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amiodarone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amiodarone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Amiodarone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Amiodarone industry.

Chapter 3: Detailed analysis of Amiodarone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Amiodarone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Amiodarone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Amiodarone Industry Trends Table 2. Amiodarone Industry Drivers Table 3. Amiodarone Industry Opportunities and Challenges Table 4. Amiodarone Industry Restraints Table 5. Global Amiodarone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Amiodarone Revenue Share by Company (2021-2026) Table 7. Global Amiodarone Sales Volume by Company (m units) & (2021-2026) Table 8. Global Amiodarone Sales Volume Share by Company (2021-2026) Table 9. Global Amiodarone Average Price (US$/k unit) of Company (2021-2026) Table 10. Global Amiodarone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Amiodarone Key Company Manufacturing Base & Headquarters Table 12. Global Amiodarone Company, Product Type & Application Table 13. Global Amiodarone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Amiodarone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Amiodarone Table 18. Significant Companies of Tablet Amiodarone Table 19. Significant Companies of Capsule Amiodarone Table 20. Global Amiodarone Sales Volume by Type 2021 VS 2025 VS 2032 (m units) Table 21. Global Amiodarone Sales Volume by Type (2021-2026) & (m units) Table 22. Global Amiodarone Sales Volume by Type (2027-2032) & (m units) Table 23. Global Amiodarone Sales Volume Share by Type (2021-2026) Table 24. Global Amiodarone Sales Volume Share by Type (2027-2032) Table 25. Global Amiodarone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Amiodarone Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Amiodarone Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Amiodarone Sales Value Share by Type (2021-2026) Table 29. Global Amiodarone Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Ventricular Tachycardia Table 31. Significant Companies of Atrial Fibrillation Table 32. Significant Companies of Cardiac Arrest Table 33. Significant Companies of Others Table 34. Global Amiodarone Sales Volume by Application 2021 VS 2025 VS 2032 (m units) Table 35. Global Amiodarone Sales Volume by Application (2021-2026) & (m units) Table 36. Global Amiodarone Sales Volume by Application (2027-2032) & (m units) Table 37. Global Amiodarone Sales Volume Share by Application (2021-2026) Table 38. Global Amiodarone Sales Volume Share by Application (2027-2032) Table 39. Global Amiodarone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Amiodarone Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Amiodarone Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Amiodarone Sales Value Share by Application (2021-2026) Table 43. Global Amiodarone Sales Value Share by Application (2027-2032) Table 44. Global Amiodarone Sales by Region: 2021 VS 2025 VS 2032 (m units) Table 45. Global Amiodarone Sales by Region (2021-2026) & (m units) Table 46. Global Amiodarone Sales Market Share by Region (2021-2026) Table 47. Global Amiodarone Sales by Region (2027-2032) & (m units) Table 48. Global Amiodarone Sales Market Share by Region (2027-2032) Table 49. Global Amiodarone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Amiodarone Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Amiodarone Sales Value Share by Region (2021-2026) Table 52. Global Amiodarone Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Amiodarone Sales Value Share by Region (2027-2032) Table 54. Global Amiodarone Market Average Price (US$/k unit) by Region (2021-2026) Table 55. Global Amiodarone Market Average Price (US$/k unit) by Region (2027-2032) Table 56. Global Amiodarone Sales by Country: 2021 VS 2025 VS 2032 (m units) Table 57. Global Amiodarone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Amiodarone Sales by Country (2021-2026) & (m units) Table 59. Global Amiodarone Sales Market Share by Country (2021-2026) Table 60. Global Amiodarone Sales by Country (2027-2032) & (m units) Table 61. Global Amiodarone Sales Market Share by Country (2027-2032) Table 62. Global Amiodarone Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Amiodarone Sales Value Market Share by Country (2021-2026) Table 64. Global Amiodarone Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Amiodarone Sales Value Market Share by Country (2027-2032) Table 66. Shanghai Pharmaceuticals Company Information Table 67. Shanghai Pharmaceuticals Business Overview Table 68. Shanghai Pharmaceuticals Amiodarone Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 69. Shanghai Pharmaceuticals Amiodarone Product Portfolio Table 70. Shanghai Pharmaceuticals Recent Development Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Amiodarone Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 74. Sanofi Amiodarone Product Portfolio Table 75. Sanofi Recent Development Table 76. Mylan Pharmaceuticals Company Information Table 77. Mylan Pharmaceuticals Business Overview Table 78. Mylan Pharmaceuticals Amiodarone Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 79. Mylan Pharmaceuticals Amiodarone Product Portfolio Table 80. Mylan Pharmaceuticals Recent Development Table 81. North China Pharmaceutical Company Company Information Table 82. North China Pharmaceutical Company Business Overview Table 83. North China Pharmaceutical Company Amiodarone Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 84. North China Pharmaceutical Company Amiodarone Product Portfolio Table 85. North China Pharmaceutical Company Recent Development Table 86. Harbin Pharmaceutical Group Company Information Table 87. Harbin Pharmaceutical Group Business Overview Table 88. Harbin Pharmaceutical Group Amiodarone Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 89. Harbin Pharmaceutical Group Amiodarone Product Portfolio Table 90. Harbin Pharmaceutical Group Recent Development Table 91. Wyeth Pharmaceuticals (Pfizer) Company Information Table 92. Wyeth Pharmaceuticals (Pfizer) Business Overview Table 93. Wyeth Pharmaceuticals (Pfizer) Amiodarone Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 94. Wyeth Pharmaceuticals (Pfizer) Amiodarone Product Portfolio Table 95. Wyeth Pharmaceuticals (Pfizer) Recent Development Table 96. Sawai Pharmaceutical Company Information Table 97. Sawai Pharmaceutical Business Overview Table 98. Sawai Pharmaceutical Amiodarone Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 99. Sawai Pharmaceutical Amiodarone Product Portfolio Table 100. Sawai Pharmaceutical Recent Development Table 101. Roemmers Company Information Table 102. Roemmers Business Overview Table 103. Roemmers Amiodarone Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 104. Roemmers Amiodarone Product Portfolio Table 105. Roemmers Recent Development Table 106. Cipla Pharmaceutical Company Information Table 107. Cipla Pharmaceutical Business Overview Table 108. Cipla Pharmaceutical Amiodarone Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 109. Cipla Pharmaceutical Amiodarone Product Portfolio Table 110. Cipla Pharmaceutical Recent Development Table 111. Arrow Pharma Pty Ltd Company Information Table 112. Arrow Pharma Pty Ltd Business Overview Table 113. Arrow Pharma Pty Ltd Amiodarone Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 114. Arrow Pharma Pty Ltd Amiodarone Product Portfolio Table 115. Arrow Pharma Pty Ltd Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Amiodarone Distributors List Table 119. Amiodarone Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Amiodarone Product Image Figure 2. Global Amiodarone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amiodarone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Amiodarone Sales (2021-2032) & (m units) Figure 5. Global Amiodarone Sales Average Price (US$/k unit) & (2021-2032) Figure 6. Global Amiodarone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Amiodarone Image Figure 10. Tablet Amiodarone Image Figure 11. Capsule Amiodarone Image Figure 12. Global Amiodarone Sales Volume by Type (2021 VS 2025 VS 2032) & (m units) Figure 13. Global Amiodarone Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Amiodarone Sales Volume Share by Type (2021-2032) Figure 15. Global Amiodarone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Amiodarone Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Amiodarone Sales Value Share by Type (2021-2032) Figure 18. Ventricular Tachycardia Image Figure 19. Atrial Fibrillation Image Figure 20. Cardiac Arrest Image Figure 21. Others Image Figure 22. Global Amiodarone Sales Volume by Application (2021 VS 2025 VS 2032) & (m units) Figure 23. Global Amiodarone Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Amiodarone Sales Volume Share by Application (2021-2032) Figure 25. Global Amiodarone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Amiodarone Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Amiodarone Sales Value Share by Application (2021-2032) Figure 28. Global Amiodarone Sales by Region: 2021 VS 2025 VS 2032 (m units) Figure 29. Global Amiodarone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Amiodarone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Amiodarone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Amiodarone Sales Value (2021-2032) & (US$ Million) Figure 33. North America Amiodarone Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Amiodarone Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Amiodarone Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Amiodarone Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Amiodarone Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Amiodarone Sales Value (2021-2032) & (US$ Million) Figure 39. South America Amiodarone Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Amiodarone Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Amiodarone Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Amiodarone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Amiodarone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Amiodarone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Amiodarone Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Amiodarone Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Amiodarone
  • Tablet Amiodarone
  • Capsule Amiodarone
Applications
  • Ventricular Tachycardia
  • Atrial Fibrillation
  • Cardiac Arrest
  • Others
Companies covered
  • Shanghai Pharmaceuticals
  • Sanofi
  • Mylan Pharmaceuticals
  • North China Pharmaceutical Company
  • Harbin Pharmaceutical Group
  • Wyeth Pharmaceuticals (Pfizer)
  • Sawai Pharmaceutical
  • Roemmers
  • Cipla Pharmaceutical
  • Arrow Pharma Pty Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Amiodarone Sales Value (2021-2032)
  4. 1.2.2 Global Amiodarone Sales Volume (2021-2032)
  5. 1.2.3 Global Amiodarone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Amiodarone Market Dynamics
  1. 2.1 Amiodarone Industry Trends
  2. 2.2 Amiodarone Industry Drivers
  3. 2.3 Amiodarone Industry Opportunities and Challenges
  4. 2.4 Amiodarone Industry Restraints
3 Amiodarone Market by Company
  1. 3.1 Global Amiodarone Company Revenue Ranking in 2025
  2. 3.2 Global Amiodarone Revenue by Company (2021-2026)
  3. 3.3 Global Amiodarone Sales Volume by Company (2021-2026)
  4. 3.4 Global Amiodarone Average Price by Company (2021-2026)
  5. 3.5 Global Amiodarone Company Ranking (2024-2026)
  6. 3.6 Global Amiodarone Company Manufacturing Base and Headquarters
  7. 3.7 Global Amiodarone Company Product Type and Application
  8. 3.8 Global Amiodarone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Amiodarone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Amiodarone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Amiodarone Market by Type
  1. 4.1 Amiodarone Type Introduction
  2. 4.1.1 Injection Amiodarone
  3. 4.1.2 Tablet Amiodarone
  4. 4.1.3 Capsule Amiodarone
  5. 4.2 Global Amiodarone Sales Volume by Type
  6. 4.2.1 Global Amiodarone Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Amiodarone Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Amiodarone Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Amiodarone Sales Value by Type
  10. 4.3.1 Global Amiodarone Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Amiodarone Sales Value by Type (2021-2032)
  12. 4.3.3 Global Amiodarone Sales Value Share by Type (2021-2032)
5 Amiodarone Market by Application
  1. 5.1 Amiodarone Application Introduction
  2. 5.1.1 Ventricular Tachycardia
  3. 5.1.2 Atrial Fibrillation
  4. 5.1.3 Cardiac Arrest
  5. 5.1.4 Others
  6. 5.2 Global Amiodarone Sales Volume by Application
  7. 5.2.1 Global Amiodarone Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Amiodarone Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Amiodarone Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Amiodarone Sales Value by Application
  11. 5.3.1 Global Amiodarone Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Amiodarone Sales Value by Application (2021-2032)
  13. 5.3.3 Global Amiodarone Sales Value Share by Application (2021-2032)
6 Amiodarone Regional Sales and Value Analysis
  1. 6.1 Global Amiodarone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Amiodarone Sales by Region (2021-2032)
  3. 6.2.1 Global Amiodarone Sales by Region: 2021-2026
  4. 6.2.2 Global Amiodarone Sales by Region (2027-2032)
  5. 6.3 Global Amiodarone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Amiodarone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Amiodarone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Amiodarone Sales Value by Region (2027-2032)
  9. 6.5 Global Amiodarone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Amiodarone Sales Value (2021-2032)
  12. 6.6.2 North America Amiodarone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Amiodarone Sales Value (2021-2032)
  15. 6.7.2 Europe Amiodarone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Amiodarone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Amiodarone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Amiodarone Sales Value (2021-2032)
  21. 6.9.2 South America Amiodarone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Amiodarone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Amiodarone Sales Value Share by Country, 2025 VS 2032
7 Amiodarone Country-level Sales and Value Analysis
  1. 7.1 Global Amiodarone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Amiodarone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Amiodarone Sales by Country (2021-2032)
  4. 7.3.1 Global Amiodarone Sales by Country (2021-2026)
  5. 7.3.2 Global Amiodarone Sales by Country (2027-2032)
  6. 7.4 Global Amiodarone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Amiodarone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Amiodarone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Amiodarone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Amiodarone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Amiodarone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Amiodarone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Amiodarone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Amiodarone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Amiodarone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Amiodarone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Amiodarone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Amiodarone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Amiodarone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Amiodarone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Amiodarone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Amiodarone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Amiodarone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Amiodarone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Amiodarone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Amiodarone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Amiodarone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Amiodarone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Amiodarone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Amiodarone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Amiodarone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Amiodarone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Amiodarone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Amiodarone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Amiodarone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Amiodarone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Amiodarone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Amiodarone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Amiodarone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Amiodarone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Amiodarone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Amiodarone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Amiodarone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Amiodarone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Amiodarone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Amiodarone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Amiodarone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Amiodarone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Amiodarone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Amiodarone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Amiodarone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Amiodarone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Amiodarone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Amiodarone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Amiodarone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Amiodarone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Amiodarone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Amiodarone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Amiodarone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Amiodarone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Amiodarone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Amiodarone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Amiodarone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Amiodarone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Amiodarone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Amiodarone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Amiodarone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Amiodarone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Amiodarone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Amiodarone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Amiodarone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Amiodarone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Amiodarone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Amiodarone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Amiodarone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Amiodarone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Amiodarone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Amiodarone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Amiodarone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Amiodarone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Amiodarone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Amiodarone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Amiodarone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Amiodarone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Amiodarone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Amiodarone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Amiodarone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Amiodarone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Amiodarone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Amiodarone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Amiodarone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Amiodarone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai Pharmaceuticals
  2. 8.1.1 Shanghai Pharmaceuticals Company Information
  3. 8.1.2 Shanghai Pharmaceuticals Business Overview
  4. 8.1.3 Shanghai Pharmaceuticals Amiodarone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai Pharmaceuticals Amiodarone Product Portfolio
  6. 8.1.5 Shanghai Pharmaceuticals Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Amiodarone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Amiodarone Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Mylan Pharmaceuticals
  14. 8.3.1 Mylan Pharmaceuticals Company Information
  15. 8.3.2 Mylan Pharmaceuticals Business Overview
  16. 8.3.3 Mylan Pharmaceuticals Amiodarone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Pharmaceuticals Amiodarone Product Portfolio
  18. 8.3.5 Mylan Pharmaceuticals Recent Developments
  19. 8.4 North China Pharmaceutical Company
  20. 8.4.1 North China Pharmaceutical Company Company Information
  21. 8.4.2 North China Pharmaceutical Company Business Overview
  22. 8.4.3 North China Pharmaceutical Company Amiodarone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 North China Pharmaceutical Company Amiodarone Product Portfolio
  24. 8.4.5 North China Pharmaceutical Company Recent Developments
  25. 8.5 Harbin Pharmaceutical Group
  26. 8.5.1 Harbin Pharmaceutical Group Company Information
  27. 8.5.2 Harbin Pharmaceutical Group Business Overview
  28. 8.5.3 Harbin Pharmaceutical Group Amiodarone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Harbin Pharmaceutical Group Amiodarone Product Portfolio
  30. 8.5.5 Harbin Pharmaceutical Group Recent Developments
  31. 8.6 Wyeth Pharmaceuticals (Pfizer)
  32. 8.6.1 Wyeth Pharmaceuticals (Pfizer) Company Information
  33. 8.6.2 Wyeth Pharmaceuticals (Pfizer) Business Overview
  34. 8.6.3 Wyeth Pharmaceuticals (Pfizer) Amiodarone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Wyeth Pharmaceuticals (Pfizer) Amiodarone Product Portfolio
  36. 8.6.5 Wyeth Pharmaceuticals (Pfizer) Recent Developments
  37. 8.7 Sawai Pharmaceutical
  38. 8.7.1 Sawai Pharmaceutical Company Information
  39. 8.7.2 Sawai Pharmaceutical Business Overview
  40. 8.7.3 Sawai Pharmaceutical Amiodarone Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sawai Pharmaceutical Amiodarone Product Portfolio
  42. 8.7.5 Sawai Pharmaceutical Recent Developments
  43. 8.8 Roemmers
  44. 8.8.1 Roemmers Company Information
  45. 8.8.2 Roemmers Business Overview
  46. 8.8.3 Roemmers Amiodarone Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Roemmers Amiodarone Product Portfolio
  48. 8.8.5 Roemmers Recent Developments
  49. 8.9 Cipla Pharmaceutical
  50. 8.9.1 Cipla Pharmaceutical Company Information
  51. 8.9.2 Cipla Pharmaceutical Business Overview
  52. 8.9.3 Cipla Pharmaceutical Amiodarone Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Cipla Pharmaceutical Amiodarone Product Portfolio
  54. 8.9.5 Cipla Pharmaceutical Recent Developments
  55. 8.10 Arrow Pharma Pty Ltd
  56. 8.10.1 Arrow Pharma Pty Ltd Company Information
  57. 8.10.2 Arrow Pharma Pty Ltd Business Overview
  58. 8.10.3 Arrow Pharma Pty Ltd Amiodarone Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Arrow Pharma Pty Ltd Amiodarone Product Portfolio
  60. 8.10.5 Arrow Pharma Pty Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Amiodarone Value Chain Analysis
  2. 9.1.1 Amiodarone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Amiodarone Sales Mode & Process
  6. 9.2 Amiodarone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Amiodarone Distributors
  9. 9.2.3 Amiodarone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst